Ava, a Switzerland-based medical technology company for women’s reproductive health backed by telecoms firm Swisscom, has raised $30m in its series B round.
The funding was provided by venture capital firms BtoV and SVC, an investment vehicle of financial services firm Credit Suisse, with the majority of the capital provided by existing, unnamed investors.
Founded in 2014, Ava produces women’s reproductive health products, and launched a fertility tracking sensor bracelet and accompanying app in July this year.
With its series B round, Ava said its cycle-tracking sensor bracelet (pictured), which precisely detects the 5.3-day fertile window in a woman’s cycle in real time, has officially reached a milestone of 10,000 pregnancies among users since launching in July 2016.
In 2016, Ava closed an oversubscribed $9.7m series A round backed by Swisscom and financial services provider Zurich Cantonal Bank (ZKB).
Venture capital firm Polytech Ecosystem Ventures led the series A round, which included Global Sources, a business-to-business media company that facilitates trade with greater China, and investment firm Blue Ocean Ventures.
The company received about Sfr2m ($2m) in seed financing from Swisscom’s corporate venturing arm, Swisscom Ventures, ZKB and unnamed angel investors in 2015, when the company took part in Swisscom’s StartUp Challenge accelerator as part of its third batch.
– Image courtesy of Ava